News

Merck’s Enflonsia receives FDA approval for RSV prophylaxis
Merck’s Enflonsia (clesrovimab) has received US Food and Drug Administration (FDA) approval for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns ...
InnovationRx: RFK Jr. Purges The Vaccine Advisory Committee
In this week’s edition of InnovationRx, we look at RFK Jr.’s vaccine advisory committee purge, a tech billionaire’s funding ...
Newly approved antibody could offer another option for protecting infants from RSV, a common infection that can be deadly
The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...
Quantum Stocks Jump as Nvidia Sees Inflection Point
CEO Jensen Huang said quantum computing is at an inflection point, sparking a premarket rally in quantum stocks after he ...